When dealing with recurring mucinous appendiceal adenocarcinoma, undergoing repeat cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) can be a game-changer. This study from MD Anderson Cancer Center reveals that patients who opt for repeat CRS/HIPEC enjoy similar recurrence-free survival compared to those initially treated, and even better overall survival than patients relying solely on […]

In patients with colorectal peritoneal metastases (CRC-PM) treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (CRS-HIPEC), systemic chemotherapy (SC) did not significantly enhance overall survival (OS). However, the timing of SC made a difference. Preoperative SC correlated with more major complications and shorter disease-free intervals, while postoperative SC resulted in longer disease-free intervals. The study […]